The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Coding Corner Answer: March

Coding Corner Answer: March

March 1, 2015 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Answer

99214-25. 96413, 96375, 96361-59, J1745 x 3 J1745 JW* x 17, J1200 x1

You Might Also Like
  • Coding Corner Answer: September
  • Rheumatology Coding Corner Answer: Billing Infusion Procedure with JW Modifier
  • Coding Corner Answer: July Coding Challenge
Explore This Issue
March 2015
Also By This Author
  • Lupus in the Child’s Mind

Diagnosis ICD-9: 714.0, 995.27, E947.8

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

ICD-10: M05.09, T50.995A

Modifier -25 is used to indicate the patient received a significant, separately identifiable E/M service on the same day as her infliximab infusion. This E/M service entailed:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • The history is expanded, problem focused;
  • The examination is detailed; and
  • The medical decision making is of moderate complexity.

The infliximab is a chemotherapy infusion and should be coded with CPT code 96413 for the first hour of the infusion. The patient had a push of diphenhydramine as a prophylactic prior to the infusion. Only one initial code can be used for the drug administration. This could be coded as an additional push. Even if this code was performed first, it is permissible to code the main code, which was the infusion, as the initial code. Because the patient’s infliximab infusion was stopped after 22 minutes, the only code for the infusion that should be coded is 96413. The initial part of the first hour can be billed, as long as it is 16 minutes or more. Keep in mind that the time does not start for the infusion until the actual medication is started, not when the IV port is inserted. The infusion of saline can be billed as long as it is used as an avenue to flush out the medication from the adverse drug reaction. This would be coded as the additional hour of hydration because there can only be one initial hour of drug administration code per session. Modifier -59 should be used to identify the hydration as distinct and separate: “… not normally reported together, but are appropriate under the circumstances.” Documentation should be noted in the patient’s record to support the different procedure that is not ordinarily encountered or performed on the same day.

J1745 is the drug HCPCS code for infliximab 10 mg, but the drug is sold as 100 mg of lyophilized infliximab in a 20 mL vial. Because the patient received 200 mg of infliximab, the correct way to code this is J1745 x 20 (20 x 10 = 200 mg). Seventeen units were wasted, so 170 mg would have to be documented as drug wastage and coded with a modifier JW to indicate drug wastage.

*Currently, Medicare does not require the use of the JW modifier, but still requires documentation in the medical record of any drug wastage. Many private carriers do require the use of the JW modifier with the wasted drug listed on a separate line, and the medical record must be documented concerning why and how much drug was wasted.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College, Practice Management Tagged With: Billing, chemotherapy, Coding, Infusion, rheumatologyIssue: March 2015

You Might Also Like:
  • Coding Corner Answer: September
  • Rheumatology Coding Corner Answer: Billing Infusion Procedure with JW Modifier
  • Coding Corner Answer: July Coding Challenge
  • Coding Corner Answer: March 2008

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)